Meeder Asset Management’s Insight Molecular Diagnostics Inc. Common Stock IMDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-9
| Closed | -$28 | – | 541 |
|
|
2023
Q3 | $28 | Sell |
9
-1
| -10% | -$3 | ﹤0.01% | 483 |
|
|
2023
Q2 | $45 | Hold |
10
| – | – | ﹤0.01% | 499 |
|
|
2023
Q1 | $69 | Hold |
10
| – | – | ﹤0.01% | 587 |
|
|
2022
Q4 | $63 | Hold |
10
| – | – | ﹤0.01% | 782 |
|
|
2022
Q3 | $0 | Sell |
10
-22
| -69% | – | ﹤0.01% | 2297 |
|
|
2022
Q2 | $0 | Sell |
32
-6
| -16% | – | ﹤0.01% | 2356 |
|
|
2022
Q1 | $1K | Buy |
+38
| New | +$1K | ﹤0.01% | 2221 |
|
|
2021
Q4 | – | Sell |
-197
| Closed | -$14K | – | 1962 |
|
|
2021
Q3 | $14K | Hold |
197
| – | – | ﹤0.01% | 1558 |
|
|
2021
Q2 | $23K | Buy |
197
+9
| +5% | +$1.05K | ﹤0.01% | 1419 |
|
|
2021
Q1 | $20K | Buy |
+188
| New | +$20K | ﹤0.01% | 1404 |
|
|
2020
Q4 | – | Sell |
-186
| Closed | -$3K | – | 2121 |
|
|
2020
Q3 | $3K | Hold |
186
| – | – | ﹤0.01% | 1741 |
|
|
2020
Q2 | $7K | Hold |
186
| – | – | ﹤0.01% | 1428 |
|
|
2020
Q1 | $9K | Buy |
186
+141
| +313% | +$6.82K | ﹤0.01% | 1563 |
|
|
2019
Q4 | $2K | Sell |
45
-2
| -4% | -$89 | ﹤0.01% | 2039 |
|
|
2019
Q3 | $2K | Buy |
+47
| New | +$2K | ﹤0.01% | 1974 |
|
|
2018
Q1 | – | Sell |
-1
| Closed | – | – | 1689 |
|
|
2017
Q4 | $0 | Buy |
+1
| New | – | ﹤0.01% | 1756 |
|